Solventum Corporation (SOLV)

USD 66.89

(-2.49%)

Market Cap (In USD)

11.55 Billion

Revenue (In USD)

8.19 Billion

Net Income (In USD)

1.34 Billion

Avg. Volume

1.4 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
47.16-77.17
PE
-
EPS
-
Beta Value
-0.25
ISIN
US83444M1018
CUSIP
-
CIK
1964738
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mr. Bryan C. Hanson
Employee Count
-
Website
https://www.solventum.com
Ipo Date
2024-04-01
Details
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.